>>Gilead has also licensed 11 manufacturers in India to produce cheaper generic versions of its hepatitis C drugs for sale in 101 developing countries. The gene

>>Gilead has also licensed 11 manufacturers in India to produce cheaper generic versions of its hepatitis C drugs for sale in 101 developing countries. The generic medications retail for $300–$900 per treatment course in countries where they are permitted... Maybe India et al politicians should steal a bit less and save lives by paying roughly 100x less that USA patients. The drug costs money to be developed and trialed, you can't just copy the finished product, otherwise no one would try again...